Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › TX › Houston › NPI 1467066860
Lab

PCLTX LLC

PCLTX LLC was paid $8.79M by Medicaid between Jun 2021 and Dec 2024, across 29 billing codes. Its largest line is 87633, Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets — 21% of everything it billed.

33Billing provider infoPCLTX LLC
HOUSTON, TX 77070
33aNPI1467066860assigned 09/02/2020
28Total paid$8.79M
24GClaims393,875
24DCodes billed29
24AFirst – last monthJun 2021 – Dec 2024
Compared with peers

Next to other Clinical Medical Laboratory providers in Texas

Rank by total paid#21 of 436
Median peer was paid$17K
This provider vs. median510×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$200K$400K$600K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
202111,322$85K
2022103,008$1.81M
2023143,703$3.15M
2024incomplete135,842$3.74M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets 21% 27,022 24,896 $1.83M
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism 17% 47,758 29,404 $1.54M
87150 9.9% 15,334 10,879 $869K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 7.8% 12,073 10,790 $689K
87481 5.3% 32,515 29,034 $462K
87653 4.4% 32,122 28,875 $385K
87640 4.4% 31,917 28,932 $383K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 4.2% 15,816 14,838 $371K
87541 3.9% 28,055 25,678 $339K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe 3.6% 30,293 27,612 $316K
87581 3.5% 28,031 25,656 $309K
87486 3.5% 28,028 25,654 $307K
17 more codes
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 2.6% 12,061 $227K
87561 2.3% 19,833 $206K
87500 2.0% 11,968 $176K
87507 1.1% 905 $97K
87631 <1% 1,324 $51K
87529 <1% 1,785 $37K
87625 <1% 1,972 $26K
87563 <1% 1,929 $26K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe <1% 2,192 $25K
87532 <1% 1,786 $22K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 1,782 $21K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 1,781 $21K
87496 <1% 1,783 $21K
86759 <1% 906 $16K
87511 <1% 1,954 $13K
86723 <1% 904 $6K
87551 <1% 46 $505.86

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialYEATES, ANDREW (CEO)
Same official

Other billing entities under YEATES, ANDREW

Full network →
ProviderLocationPaid
Physicians Group Laboratories, LLCHouma, LA$208.13M

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.